Switch theme
Sign up to access all valuation multiples
Cinkarna Celje is principally engaged in the production and marketing of titanium dioxide pigment. The company has six operating segments; The titanium dioxides segment comprises the sale of titanium dioxide pigment, Zinc processing segment comprises sales of metallurgical products, Paints, varnishes, mastics, and printing inks segment, the Agro programme segment comprises sales of copper fungicides and Humovit, polymers and the Other segment comprises sales of CEGIPS, sulphuric acid, polymers, service activities, holiday accommodation, etc. The company's geographical segments are Slovenia, the European Union, third countries, and the markets of the former Yugoslavia.
1873
718
Last FY Revenue $225M
Last FY EBITDA $46.7M
$283M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Cinkarna Celje achieved revenue of $225M and an EBITDA of $46.7M.
Cinkarna Celje expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cinkarna Celje valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $225M | XXX | XXX | XXX |
| Gross Profit | XXX | $83.1M | XXX | XXX | XXX |
| Gross Margin | XXX | 37% | XXX | XXX | XXX |
| EBITDA | XXX | $46.7M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 21% | XXX | XXX | XXX |
| EBIT | XXX | $29.3M | XXX | XXX | XXX |
| EBIT Margin | XXX | 13% | XXX | XXX | XXX |
| Net Profit | XXX | $25.9M | XXX | XXX | XXX |
| Net Margin | XXX | 12% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cinkarna Celje's stock price is EUR 35 (or $39).
Cinkarna Celje has current market cap of EUR 271M (or $304M), and EV of EUR 252M (or $283M).
See Cinkarna Celje trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $283M | $304M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cinkarna Celje has market cap of $304M and EV of $283M.
Cinkarna Celje's trades at 1.3x EV/Revenue multiple, and 6.1x EV/EBITDA.
Equity research analysts estimate Cinkarna Celje's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cinkarna Celje's P/E ratio is not available.
See valuation multiples for Cinkarna Celje and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $304M | XXX | $304M | XXX | XXX | XXX |
| EV (current) | $283M | XXX | $283M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 6.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 9.7x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 11.7x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 6.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCinkarna Celje's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Cinkarna Celje's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cinkarna Celje's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cinkarna Celje and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 24% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cinkarna Celje acquired XXX companies to date.
Last acquisition by Cinkarna Celje was XXXXXXXX, XXXXX XXXXX XXXXXX . Cinkarna Celje acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cinkarna Celje founded? | Cinkarna Celje was founded in 1873. |
| Where is Cinkarna Celje headquartered? | Cinkarna Celje is headquartered in Slovenia. |
| How many employees does Cinkarna Celje have? | As of today, Cinkarna Celje has 718 employees. |
| Is Cinkarna Celje publicy listed? | Yes, Cinkarna Celje is a public company listed on LJU. |
| What is the stock symbol of Cinkarna Celje? | Cinkarna Celje trades under CICG ticker. |
| When did Cinkarna Celje go public? | Cinkarna Celje went public in 1998. |
| Who are competitors of Cinkarna Celje? | Similar companies to Cinkarna Celje include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of Cinkarna Celje? | Cinkarna Celje's current market cap is $304M |
| Is Cinkarna Celje profitable? | Yes, Cinkarna Celje is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
